- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x DKA- ARG- VAL- LYS- AR7- 0QE: DECANOYL-ARG-VAL-LYS-ARG-CHLOROMETHYLKETONE INHIBITOR(Non-covalent)
- 1 x NAG- NAG- BMA- MAN- NAG- GAL- NAG- GAL- MAN- NAG- FUL: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-[beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG-BMA-MAN-NAG-GAL-NAG-GAL-MAN-NAG-FUL.2: 13 residues within 4Å:- Chain A: N.333
- Chain B: R.23, R.191, F.216, N.218, V.219, W.221, L.299, N.300, A.301, D.302, W.304, A.411
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:N.300
- Hydrogen bonds: B:A.301, B:A.411
- Water bridges: B:L.299, B:W.304
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CA: CALCIUM ION(Non-covalent)
CA.4: 6 residues within 4Å:- Chain A: D.8, D.55, V.98, N.101, V.103, G.105
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.8, A:D.55, A:V.98, A:V.103, A:G.105
CA.5: 4 residues within 4Å:- Chain A: D.151, D.194, E.224
- Ligands: DKA-ARG-VAL-LYS-AR7-0QE.1
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.151, A:D.194, A:E.224, A:E.224, H2O.8
CA.20: 6 residues within 4Å:- Chain B: D.8, D.55, V.98, N.101, V.103, G.105
5 PLIP interactions:5 interactions with chain B- Metal complexes: B:D.8, B:D.55, B:V.98, B:V.103, B:G.105
CA.21: 4 residues within 4Å:- Chain B: D.151, D.194, E.224
- Ligands: DKA-ARG-VAL-LYS-AR7-0QE.18
5 PLIP interactions:3 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.151, B:D.194, B:E.224, H2O.20, H2O.22
- 19 x SO4: SULFATE ION(Non-functional Binders)
SO4.6: 5 residues within 4Å:- Chain A: R.86, H.87, R.90, H.257
- Ligands: DKA-ARG-VAL-LYS-AR7-0QE.1
Ligand excluded by PLIPSO4.7: 1 residues within 4Å:- Chain A: R.86
Ligand excluded by PLIPSO4.8: 3 residues within 4Å:- Chain A: S.387, G.454, T.455
Ligand excluded by PLIPSO4.9: 1 residues within 4Å:- Chain A: K.458
Ligand excluded by PLIPSO4.10: 3 residues within 4Å:- Chain A: E.123, T.125, D.126
Ligand excluded by PLIPSO4.11: 4 residues within 4Å:- Chain A: G.39, N.138, H.141, K.279
Ligand excluded by PLIPSO4.12: 2 residues within 4Å:- Chain A: H.373
- Ligands: NAG-NAG-BMA-FUC.19
Ligand excluded by PLIPSO4.13: 4 residues within 4Å:- Chain A: C.253, T.254, E.255, S.256
Ligand excluded by PLIPSO4.14: 3 residues within 4Å:- Chain A: K.154, H.414, Y.416
Ligand excluded by PLIPSO4.15: 3 residues within 4Å:- Chain A: P.77, R.78, Y.79
Ligand excluded by PLIPSO4.16: 3 residues within 4Å:- Chain A: E.164, Q.381, R.383
Ligand excluded by PLIPSO4.17: 2 residues within 4Å:- Ligands: DKA-ARG-VAL-LYS-AR7-0QE.1, DKA-ARG-VAL-LYS-AR7-0QE.1
Ligand excluded by PLIPSO4.22: 6 residues within 4Å:- Chain A: R.376
- Chain B: T.21, Q.22, N.26, K.295, D.323
Ligand excluded by PLIPSO4.23: 5 residues within 4Å:- Chain B: R.86, H.87, R.90, H.257
- Ligands: DKA-ARG-VAL-LYS-AR7-0QE.18
Ligand excluded by PLIPSO4.24: 1 residues within 4Å:- Chain B: R.86
Ligand excluded by PLIPSO4.25: 3 residues within 4Å:- Chain B: E.123, T.125, D.126
Ligand excluded by PLIPSO4.26: 3 residues within 4Å:- Chain B: N.138, H.141, K.279
Ligand excluded by PLIPSO4.27: 3 residues within 4Å:- Chain B: T.254, E.255, S.256
Ligand excluded by PLIPSO4.28: 3 residues within 4Å:- Ligands: DKA-ARG-VAL-LYS-AR7-0QE.18, DKA-ARG-VAL-LYS-AR7-0QE.18, DKA-ARG-VAL-LYS-AR7-0QE.18
Ligand excluded by PLIP- 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Henrich, S. et al., The Crystal Structure of the Proprotein Processing Proteinase Furin Explains its Stringent Specificity. Nat.Struct.Biol. (2003)
- Release Date
- 2003-07-08
- Peptides
- Furin precursor: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
G
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.60 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x DKA- ARG- VAL- LYS- AR7- 0QE: DECANOYL-ARG-VAL-LYS-ARG-CHLOROMETHYLKETONE INHIBITOR(Non-covalent)
- 1 x NAG- NAG- BMA- MAN- NAG- GAL- NAG- GAL- MAN- NAG- FUL: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-[beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[beta-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CA: CALCIUM ION(Non-covalent)
- 19 x SO4: SULFATE ION(Non-functional Binders)
- 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Henrich, S. et al., The Crystal Structure of the Proprotein Processing Proteinase Furin Explains its Stringent Specificity. Nat.Struct.Biol. (2003)
- Release Date
- 2003-07-08
- Peptides
- Furin precursor: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
G